1918 Influenza pandemic caused by highly conserved viruses with two receptor-binding variants

Emerging Infectious Diseases

Volumn 9, Issue 10, 2003, Pages 1249-1253

  Reid, Ann H ^a   Janczewski, Thomas A ^a   Lourens, Raina M ^a   Eillot, Alex J ^b   Daniels, Rod S ^b   Berry, Colin L ^c   Oxford, John S ^c,d   Taubenberger, Jeffery K ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d London BioScience Innovation Center   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ;

ARTICLE; AUTOPSY; AUTUMN; BINDING KINETICS; BINDING SITE; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; INFLUENZA; NONHUMAN; NUCLEOTIDE SEQUENCE; RECEPTOR BINDING; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SPAIN; STRAIN DIFFERENCE; VIRAL GENETICS; VIRUS REPLICATION; VIRUS STRAIN; WINTER;

EID: 0041699148     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0910.020789     Document Type: Article

References (31)

1. Crosby A. America's forgotten pandemic. Cambridge: Cambridge University Press; 1989.
2. Jordan E. Epidemic influenza: a survey. Chicago: American Medical Association; 1927.
3. Reid AH, Taubenberger JK, Fanning TG. The 1918 Spanish influenza: integrating history and biology. Microbes Infect 2001;3:81-7.
4. Taubenberger JK, Reid AH, Janczewski TA, Fanning TG. Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Philos Trans R Soc Lond B Biol Sci 2001;356:1829-39.
5. Patterson KD, Pyle GF. The geography and mortality of the 1918 influenza pandemic. Bull Hist Med 1991;65:4-21.
6. Wright PE, Webster RG. Orthomyxoviruses. In: Knipe DM, Howley PM, editors. Fields virology. Vol 1. Philadelphia: Lippincott Williams and Wilkins; 2001:1533-79.
7. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992;56:152-79.
8. Lamb RA, Takeda M. Death by influenza virus protein. Nat Med 2001;7:1286-8.
9. Parvin JD, Smith FI, Palese P. Rapid RNA sequencing using double-stranded template DNA, SP6 polymerase, and 3′-deoxynucleotide triphosphates. DNA. 1986;5:167-71.
10. Hay AJ, Gregory V, Douglas AR, Lin YP. The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci 2001;356:1861-70.
11. Centers for Disease Control and Prevention. Influenza summary update: 2001-2 influenza season summary. June 10, 2002. [Accessed September 23, 2002]. Available from: URL: http://www.cdc.gov/nci-dod/diseases/flu/weeklyarchives/01-02summary.htm
12. Kilbourne E. Influenza pandemics in perspective. JAMA 1977;237:1225-8.
13. Schild GC, Oxford JS, de Jong JC, Webster RG. Evidence for host-cell selection of influenza virus antigenic variants. Nature 1983;303:706-9.
14. Gambaryan A, Tuzikov A, Piskarev V, Yamnikova SS, Lvov DK, Robertson JS, et al. Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic siatylglycopolymers: non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6′-sialyl(N-acetyllactosamine). Virology 1997;232:345-50.
15. Reid AH, Fanning TG, Hultin JV, Taubenberger JK. Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene. Proc Natl Acad Sci U S A 1999;96:1651-6.
16. Taubenberger JK, Reid AH, Krafft AE, Bijwaard KE, Fanning TG. Initial genetic characterization of the 1918 "Spanish" influenza virus [see comments]. Science. 1997;275:1793-6.
17. Winternitz MC, Wason IM, McNamara FP. The pathology of influenza. New Haven (CT): Yale University Press; 1920.
18. Wolbach SB. Comments on the pathology and bacteriology of fatal influenza cases, as observed at Camp Devens, Mass. Johns Hopkins Hospital Bulletin 1919;30:104.
19. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 1982;31:417-27.
20. Raymond F, Caton A, Cox N, Kendal AP, Brownlee GG. The antigenicity and evolution of influenza H1 haemagglutinin, from 1950-57 and 1977-1983: two pathways from one gene. Virology 1986;148:275-87.
21. Matrosovich M, Gambaryan A, Teneberg S, Piskarev VE, Yamnikova SS, Lvov DK, et al. Avian influenza A viruses differ from human viruses by recognition of sialyloigosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. Virology 1997;233:224-34.
22. Rogers G, D'Souza B. Receptor binding properties of human and animal HI influenza virus isolates. Virology 1989;173:317-22.
23. Matrosovich MN, Gambaryan AS, Tuzikov AB, Byramova NE, Mochalova LV, Golbraikh AA, et al. Probing of the receptor-binding sites of the H1 and H3 influenza A and influenza B virus hemagglutinins by synthetic and natural sialosides. Virology 1993;196:111-21.
24. Matrosovich M, Tuzikov A, Bovin N, Gambaryan A, Klimov A, Castrucci MR, et al. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J Virol 2000;74:8502-12.
25. Coiras MT, Aguilar JC, Galiano M, Carlos S, Gregory V, Lin YP, et al. Rapid molecular analysis of the haemagglutinin gene of human influenza A H3N2 viruses isolated in Spain from 1996 to 2000. Arch Virol 2001;146:2133-47.
26. Macken C, Lu H, Goodman J, Boykin L. The value of a database in surveillance and vaccine selection. In: Osterhaus A, Cox N, Hampson A, editors. Options for the control of influenza IV. Amsterdam: Excerpta Medica; 2001. p. 103-6.
27. Reid AH, Taubenberger JK. The 1918 flu and other influenza pandemics: "over there" and back again. Lab Invest 1999;79:95-101.
28. Fosso C. Alone with death on the Tundra. In: Hedin R, Holthaus G, editors. Alaska: Reflections on land and spirit. Tucscon (AZ): University of Arizona Press; 1989. p. 215-22.
29. Connor R, Kawaoka Y, Webster R, Paulson J. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 1994;205:17-23.
30. Gensheimer KF, Fukuda K, Brammer L, Cox N, Patriarca PA, Strikes RA. Preparing for pandemic influenza: the need for enhanced surveillance. Vaccine 2002;20(Suppl 2):S63-5.
31. Hayden FG. Perspectives on antiviral use during pandemic influenza. Philos Trans R Soc Lond B Biol Sci 2001;356:1877-84.